The Catlin Perspective is a compilation of thoughts from Don and Oliver Catlin. Together they direct the activities of The Catlin Consortium, a leading group of research organizations dedicated to ensuring the safety of over-the-counter products for consumers and clean competing environments for athletes. The Los Angeles-based nonprofit/NGO Anti-Doping Research, Inc. (ADR) and the companies Anti-Doping Sciences Institute (ADSI) and Banned Substances Control Group (BSCG) make up the consortium.
Don Catlin, M.D., is a renowned anti-doping and toxicology expert and considered a father of drug testing in sports. In 1982, he founded the UCLA Olympic Analytical Laboratory, the first anti-doping lab in the United States, and served at its director for 25 years. He oversaw drug testing at the Olympic, professional, collegiate and high school levels, and grew the lab into the world’s largest testing facility for performance-enhancing drugs. Today he directs the scientific activities for the consortium and serves as CEO and President of ADR and Chief Science Officer for ADSI and BSCG.
Oliver Catlin has a background in financial analysis, enterprise resource planning, and human resources/benefits/compensation. A graduate of UC Berkeley’s Haas School of Business, Oliver joined his father in 2004 to create their combined vision of a dynamic group of companies devoted to clean competition and safety of over-the-counter products. He served as Director of Finance and Administration at the UCLA Olympic Analytical Laboratory for two years before focusing full time on the consortium. Today he leads the business activities for the consortium and serves as President of ADSI and BSCG, and Vice President and Chief Financial Officer of ADR.